Kezar Life Sciences EPS Diluted (Quarterly YoY Growth) Trends

Kezar Life Sciences, Inc. (KZR)

7.29 -0.07 (-0.95%) USD | NASDAQ | May 08, 16:00

7.41 +0.12 (+1.65%) After-Hours: 20:00

View EPS Diluted (Quarterly YoY Growth) for KZR.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Diluted (Quarterly YoY Growth) Chart

Start Trial

View Historical Data

Start Trial

View EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Diluted (Quarterly YoY Growth) Benchmarks

Start Trial

Apellis Pharmaceuticals, Inc.	Upgrade
ACADIA Pharmaceuticals, Inc.	Upgrade
Alnylam Pharmaceuticals, Inc.	Upgrade
Savara, Inc.	Upgrade
BioMarin Pharmaceutical, Inc.	Upgrade